EFFICACY OF LOW-DOSE ISOTRETINOIN COMBINED WITH TOPICAL NIACINAMIDE IN MODERATE ACNE VULGARIS: A RANDOMIZED CONTROLLED TRIAL

Authors

  • Nazarova Shabnam Otajon kizi Asia International University image/svg+xml Author

Keywords:

acne vulgaris, isotretinoin, niacinamide, low-dose retinoid, randomized controlled trial, dermatology

Abstract

Acne vulgaris remains one of the most prevalent dermatological conditions worldwide, yet optimal treatment protocols for moderate disease continue to be debated. Isotretinoin at standard doses is effective but associated with significant adverse effects, limiting its use.

References

1. Tan JKL, Bhate K. A global perspective on the epidemiology of acne. Br J Dermatol. 2015;172 Suppl 1:3–12. doi:10.1111/bjd.13462

2. Halvorsen JA, Stern RS, Dalgard F, Thoresen M, Bjertness E, Lien L. Suicidal ideation, mental health problems, and social impairment are increased in adolescents with acne: a population-based study. J Invest Dermatol. 2011;131(2):363–370. doi:10.1038/jid.2010.264

3. Layton AM, Dreno B, Gollnick HP, Zouboulis CC. A review of the European Directive for prescribing systemic isotretinoin for acne vulgaris. J Eur Acad Dermatol Venereol. 2006;20(7):773–784. doi:10.1111/j.1468-3083.2006.01631.x

4. Chivot M. Retinoid therapy for acne. A comparative review. Am J Clin Dermatol. 2005;6(1):13–19. doi:10.2165/00128071-200506010-00002

5. Wohlrab J, Kreft D. Niacinamide – mechanisms of action and its topical use in dermatology. Skin Pharmacol Physiol. 2014;27(6):311–315. doi:10.1159/000360204

6. Borghi A, Mantovani L, Minghetti S, Virgili A, Bettoli V. Low-cumulative dose isotretinoin treatment in mild-to-moderate acne: efficacy in achieving stable remission. J Eur Acad Dermatol Venereol. 2011;25(9):1094–1098. doi:10.1111/j.1468-3083.2010.03918.x

7. Rademaker M. Isotretinoin: dose, duration and relapse. What does 30 years of usage tell us? Australas J Dermatol. 2013;54(3):157–162. doi:10.1111/ajd.12024

8. Quereux G, Volteau C, N’Guyen JM, Dreno B. Prospective study of risk factors of relapse after treatment of acne with oral isotretinoin. Dermatology. 2006;212(2):168–176. doi:10.1159/000090661

Downloads

Published

2026-06-19